Table 2.
Safety professional category | Label | Count | %Total |
---|---|---|---|
Geographic region | Asia Pacific | 6 | 9 |
Europe | 22 | 34 | |
North America | 37 | 57 | |
Total | 65 | 100 | |
Safety science work area | Immunologya | 19 | 29 |
Early development | 11 | 17 | |
Mature products | 9 | 14 | |
Oncologyb | 26 | 40 | |
Total | 65 | 100 | |
Causality assessment experience (total no. of ICSRs) | < 50 | 14 | 24 |
> 50–100 | 4 | 7 | |
> 100–150 | 7 | 12 | |
> 150–200 | 2 | 3 | |
> 200–250 | 3 | 5 | |
> 250 | 29 | 49 | |
Totalc | 59 | 91 |
aA single individual from the central nervous system group was combined into the immunology safety science work area
bOne individual in both early development and oncology was combined into the oncology safety science work area
cSix individuals did not specify an experience level